Showing results (101-110 of 113) with videos related to
Sort By:
Pageof 12
Plos One|March 26, 2013
High-intensity endurance training results in faster vessel-specific rate of vasorelaxation in type 1 diabetic ratsJuan M Murias, Adwitia Dey, Oscar A Campos, et al.Journal De Physiologie|January 1, 1990
Clues to the multi-phasic inhibitory action of botulinum neurotoxins on release of transmittersJ O Dolly, A C Ashton, C McInnes, et al.Diabetes & Metabolism|March 26, 2013
A model of poorly controlled type 1 Diabetes Mellitus and its treatment with aerobic exercise trainingC W J Melling, K N Grisé, C P Hasilo, et al.European Journal of Biochemistry|November 15, 1988
Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter releaseE A Maisey, J D Wadsworth, B Poulain, et al.International Journal of Cosmetic Science|May 24, 2008
Erroneous gender differences in axillary skin surface/sweat pHJ S Burry, H F Coulson, I Esser, et al.Medical Microbiology and Immunology|January 1, 1987
Follow-up report on 50 subjects vaccinated against herpes genitalis with Skinner vaccineG R Skinner, C G Fink, M Cowan, et al.Medical Microbiology and Immunology|January 1, 1992
Report of twelve years experience in open study of Skinner herpes simplex vaccine towards prevention of herpes genitalisG R Skinner, C Fink, J Melling, et al.European Journal of Biochemistry|April 20, 1990
The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding geneD E Thompson, J K Brehm, J D Oultram, et al.Epidemiology and Infection|November 24, 1998
Viral haemorrhagic disease of rabbits and human healthJ A Carman, M G Garner, M G Catton, et al.Medical Microbiology and Immunology|January 1, 1987
Antibody reactivity with Skinner HSV vaccineE M Muniu, J Durham, D Shariff, et al.Pageof 12